Gladstone Institutional Advisory LLC A Ikido Pharma Inc. Transaction History
Gladstone Institutional Advisory LLC
- $2.07 Billion
- Q1 2025
A detailed history of Gladstone Institutional Advisory LLC transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 24,000 shares of AIKI stock, worth $91,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,000Holding current value
$91,200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AIKI
# of Institutions
22Shares Held
790KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA189KShares$717,9300.0% of portfolio
-
Pfg Investments, LLC Woodbury, NY142KShares$537,7300.04% of portfolio
-
Exodus Point Capital Management, LP New York, NY110KShares$418,0000.0% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Geode Capital Management, LLC Boston, MA64.4KShares$244,7840.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...